Supporting data for: Identifying market risk for substandard and falsified medicines: an analytic framework based on qualitative research in China, Indonesia, Turkey and Romania.
<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a research archivist expert in dataset metadata. Answer the question truthfully.  <|eot_id|><|start_header_id|>user<|end_header_id|> Here is the Description of a dataset. Description:'This dataset contains supporting data for a study of the political and economic drivers of substandard and falsified medicines in middle income countries, led by Elizabeth Pisani. The full title of the paper is: Identifying market risk for substandard and falsified medicines: an analytic framework based on qualitative research in China, Indonesia, Turkey and Romania' . Please return only a json list of at most 3 Keywords corresponding to the Description:.<|eot_id|><|start_header_id|>assistant<|end_header_id|> {"Answer" : ["Medicine quality, Substandard medicine, Falsified medicine, Counterfeit medicine, political economy, China, Indonesia, Turkey, Romania, Pharmaceutical market, Health systems, Universal Health Coverage"]} <|eot_id|>
 Here is the Description of a dataset. Description:'This dataset contains supporting data for a study of the political and economic drivers of substandard and falsified medicines in middle income countries, led by Elizabeth Pisani. The full title of the paper is: Identifying market risk for substandard and falsified medicines: an analytic framework based on qualitative research in China, Indonesia, Turkey and Romania' . Please return only a json list of at most 3 Keywords corresponding to the Description:.
This dataset contains supporting data for a study of the political and economic drivers of substandard and falsified medicines in middle income countries, led by Elizabeth Pisani. The full title of the paper is: Identifying market risk for substandard and falsified medicines: an analytic framework based on qualitative research in China, Indonesia, Turkey and Romania
Medicine quality, Substandard medicine, Falsified medicine, Counterfeit medicine, political economy, China, Indonesia, Turkey, Romania, Pharmaceutical market, Health systems, Universal Health Coverage